Schneidawind reported that administration of G-CSF- donor lymphocyte infusion (DLI) results in graft-versus-leukemia effects without exacerbating GVHD because of the M-MDSCs in the DLI component [67]. This evidence concerns the gene CSF3 and graft versus host disease.